Report Detail

Service & Software Global Synthetic Biology in Medical Market Growth (Status and Outlook) 2022-2028

  • RnM4490406
  • |
  • 15 September, 2022
  • |
  • Global
  • |
  • 100 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

The global market for Synthetic Biology in Medical is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Synthetic Biology in Medical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Synthetic Biology in Medical players cover Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies and Arzeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Synthetic Biology in Medical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Synthetic Biology in Medical market, with both quantitative and qualitative data, to help readers understand how the Synthetic Biology in Medical market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Synthetic Biology in Medical market and forecasts the market size by Type (Genome Engineering, NGS and Cloning and Sequencing), by Application (Drug Discovery And Therapeutics, Pharmaceuticals and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Genome Engineering
NGS
Cloning and Sequencing

Segmentation by application
Drug Discovery And Therapeutics
Pharmaceuticals
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Thermo Fisher Scientific
Novozymes
Merck KGaA
Agilent Technologies
Arzeda
Codexis
Ginkgo Bioworks
Precigen
Genscript Biotech Corp
TeselaGen
Integrated DNA Technologies
Twist Bioscience
New England Biolabs

Chapter Introduction
Chapter 1: Scope of Synthetic Biology in Medical, Research Methodology, etc.
Chapter 2: Executive Summary, global Synthetic Biology in Medical market size and CAGR, Synthetic Biology in Medical market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Synthetic Biology in Medical revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Synthetic Biology in Medical revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Synthetic Biology in Medical market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies, Arzeda, Codexis, Ginkgo Bioworks, Precigen and Genscript Biotech Corp, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Synthetic Biology in Medical Market Size 2017-2028
    • 2.1.2 Synthetic Biology in Medical Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Synthetic Biology in Medical Segment by Type
    • 2.2.1 Genome Engineering
    • 2.2.2 NGS
    • 2.2.3 Cloning and Sequencing
  • 2.3 Synthetic Biology in Medical Market Size by Type
    • 2.3.1 Synthetic Biology in Medical Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Synthetic Biology in Medical Market Size Market Share by Type (2017-2022)
  • 2.4 Synthetic Biology in Medical Segment by Application
    • 2.4.1 Drug Discovery And Therapeutics
    • 2.4.2 Pharmaceuticals
    • 2.4.3 Other
  • 2.5 Synthetic Biology in Medical Market Size by Application
    • 2.5.1 Synthetic Biology in Medical Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Synthetic Biology in Medical Market Size Market Share by Application (2017-2022)

3 Synthetic Biology in Medical Market Size by Player

  • 3.1 Synthetic Biology in Medical Market Size Market Share by Players
    • 3.1.1 Global Synthetic Biology in Medical Revenue by Players (2020-2022)
    • 3.1.2 Global Synthetic Biology in Medical Revenue Market Share by Players (2020-2022)
  • 3.2 Global Synthetic Biology in Medical Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Synthetic Biology in Medical by Regions

  • 4.1 Synthetic Biology in Medical Market Size by Regions (2017-2022)
  • 4.2 Americas Synthetic Biology in Medical Market Size Growth (2017-2022)
  • 4.3 APAC Synthetic Biology in Medical Market Size Growth (2017-2022)
  • 4.4 Europe Synthetic Biology in Medical Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Synthetic Biology in Medical Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Synthetic Biology in Medical Market Size by Country (2017-2022)
  • 5.2 Americas Synthetic Biology in Medical Market Size by Type (2017-2022)
  • 5.3 Americas Synthetic Biology in Medical Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Synthetic Biology in Medical Market Size by Region (2017-2022)
  • 6.2 APAC Synthetic Biology in Medical Market Size by Type (2017-2022)
  • 6.3 APAC Synthetic Biology in Medical Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Synthetic Biology in Medical by Country (2017-2022)
  • 7.2 Europe Synthetic Biology in Medical Market Size by Type (2017-2022)
  • 7.3 Europe Synthetic Biology in Medical Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Synthetic Biology in Medical by Region (2017-2022)
  • 8.2 Middle East & Africa Synthetic Biology in Medical Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Synthetic Biology in Medical Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Synthetic Biology in Medical Market Forecast

  • 10.1 Global Synthetic Biology in Medical Forecast by Regions (2023-2028)
    • 10.1.1 Global Synthetic Biology in Medical Forecast by Regions (2023-2028)
    • 10.1.2 Americas Synthetic Biology in Medical Forecast
    • 10.1.3 APAC Synthetic Biology in Medical Forecast
    • 10.1.4 Europe Synthetic Biology in Medical Forecast
    • 10.1.5 Middle East & Africa Synthetic Biology in Medical Forecast
  • 10.2 Americas Synthetic Biology in Medical Forecast by Country (2023-2028)
    • 10.2.1 United States Synthetic Biology in Medical Market Forecast
    • 10.2.2 Canada Synthetic Biology in Medical Market Forecast
    • 10.2.3 Mexico Synthetic Biology in Medical Market Forecast
    • 10.2.4 Brazil Synthetic Biology in Medical Market Forecast
  • 10.3 APAC Synthetic Biology in Medical Forecast by Region (2023-2028)
    • 10.3.1 China Synthetic Biology in Medical Market Forecast
    • 10.3.2 Japan Synthetic Biology in Medical Market Forecast
    • 10.3.3 Korea Synthetic Biology in Medical Market Forecast
    • 10.3.4 Southeast Asia Synthetic Biology in Medical Market Forecast
    • 10.3.5 India Synthetic Biology in Medical Market Forecast
    • 10.3.6 Australia Synthetic Biology in Medical Market Forecast
  • 10.4 Europe Synthetic Biology in Medical Forecast by Country (2023-2028)
    • 10.4.1 Germany Synthetic Biology in Medical Market Forecast
    • 10.4.2 France Synthetic Biology in Medical Market Forecast
    • 10.4.3 UK Synthetic Biology in Medical Market Forecast
    • 10.4.4 Italy Synthetic Biology in Medical Market Forecast
    • 10.4.5 Russia Synthetic Biology in Medical Market Forecast
  • 10.5 Middle East & Africa Synthetic Biology in Medical Forecast by Region (2023-2028)
    • 10.5.1 Egypt Synthetic Biology in Medical Market Forecast
    • 10.5.2 South Africa Synthetic Biology in Medical Market Forecast
    • 10.5.3 Israel Synthetic Biology in Medical Market Forecast
    • 10.5.4 Turkey Synthetic Biology in Medical Market Forecast
    • 10.5.5 GCC Countries Synthetic Biology in Medical Market Forecast
  • 10.6 Global Synthetic Biology in Medical Forecast by Type (2023-2028)
  • 10.7 Global Synthetic Biology in Medical Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Information
    • 11.1.2 Thermo Fisher Scientific Synthetic Biology in Medical Product Offered
    • 11.1.3 Thermo Fisher Scientific Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Thermo Fisher Scientific Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Latest Developments
  • 11.2 Novozymes
    • 11.2.1 Novozymes Company Information
    • 11.2.2 Novozymes Synthetic Biology in Medical Product Offered
    • 11.2.3 Novozymes Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Novozymes Main Business Overview
    • 11.2.5 Novozymes Latest Developments
  • 11.3 Merck KGaA
    • 11.3.1 Merck KGaA Company Information
    • 11.3.2 Merck KGaA Synthetic Biology in Medical Product Offered
    • 11.3.3 Merck KGaA Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Merck KGaA Main Business Overview
    • 11.3.5 Merck KGaA Latest Developments
  • 11.4 Agilent Technologies
    • 11.4.1 Agilent Technologies Company Information
    • 11.4.2 Agilent Technologies Synthetic Biology in Medical Product Offered
    • 11.4.3 Agilent Technologies Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Agilent Technologies Main Business Overview
    • 11.4.5 Agilent Technologies Latest Developments
  • 11.5 Arzeda
    • 11.5.1 Arzeda Company Information
    • 11.5.2 Arzeda Synthetic Biology in Medical Product Offered
    • 11.5.3 Arzeda Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Arzeda Main Business Overview
    • 11.5.5 Arzeda Latest Developments
  • 11.6 Codexis
    • 11.6.1 Codexis Company Information
    • 11.6.2 Codexis Synthetic Biology in Medical Product Offered
    • 11.6.3 Codexis Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Codexis Main Business Overview
    • 11.6.5 Codexis Latest Developments
  • 11.7 Ginkgo Bioworks
    • 11.7.1 Ginkgo Bioworks Company Information
    • 11.7.2 Ginkgo Bioworks Synthetic Biology in Medical Product Offered
    • 11.7.3 Ginkgo Bioworks Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Ginkgo Bioworks Main Business Overview
    • 11.7.5 Ginkgo Bioworks Latest Developments
  • 11.8 Precigen
    • 11.8.1 Precigen Company Information
    • 11.8.2 Precigen Synthetic Biology in Medical Product Offered
    • 11.8.3 Precigen Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Precigen Main Business Overview
    • 11.8.5 Precigen Latest Developments
  • 11.9 Genscript Biotech Corp
    • 11.9.1 Genscript Biotech Corp Company Information
    • 11.9.2 Genscript Biotech Corp Synthetic Biology in Medical Product Offered
    • 11.9.3 Genscript Biotech Corp Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Genscript Biotech Corp Main Business Overview
    • 11.9.5 Genscript Biotech Corp Latest Developments
  • 11.10 TeselaGen
    • 11.10.1 TeselaGen Company Information
    • 11.10.2 TeselaGen Synthetic Biology in Medical Product Offered
    • 11.10.3 TeselaGen Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 TeselaGen Main Business Overview
    • 11.10.5 TeselaGen Latest Developments
  • 11.11 Integrated DNA Technologies
    • 11.11.1 Integrated DNA Technologies Company Information
    • 11.11.2 Integrated DNA Technologies Synthetic Biology in Medical Product Offered
    • 11.11.3 Integrated DNA Technologies Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Integrated DNA Technologies Main Business Overview
    • 11.11.5 Integrated DNA Technologies Latest Developments
  • 11.12 Twist Bioscience
    • 11.12.1 Twist Bioscience Company Information
    • 11.12.2 Twist Bioscience Synthetic Biology in Medical Product Offered
    • 11.12.3 Twist Bioscience Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Twist Bioscience Main Business Overview
    • 11.12.5 Twist Bioscience Latest Developments
  • 11.13 New England Biolabs
    • 11.13.1 New England Biolabs Company Information
    • 11.13.2 New England Biolabs Synthetic Biology in Medical Product Offered
    • 11.13.3 New England Biolabs Synthetic Biology in Medical Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 New England Biolabs Main Business Overview
    • 11.13.5 New England Biolabs Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Synthetic Biology in Medical. Industry analysis & Market Report on Synthetic Biology in Medical is a syndicated market report, published as Global Synthetic Biology in Medical Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Synthetic Biology in Medical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,286.68
6,573.36
3,733.20
7,466.40
530,151.00
1,060,302.00
298,692.60
597,385.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report